Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychiatr Serv 58:79-84, January 2007
doi: 10.1176/appi.ps.58.1.79
© 2007 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Supplemental figures
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Raymond, C. B.
* Articles by Caetano, P. A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Raymond, C. B.
* Articles by Caetano, P. A.
Related Collections
* Other Health Services Issues
* Antidepressants
*Related Article

Article

Antidepressant Utilization in British Columbia From 1996 to 2004: Increasing Prevalence but Not Incidence

Colette B. Raymond, Pharm.D., Steven G. Morgan, Ph.D. and Patricia A. Caetano, Ph.D.

OBJECTIVES: Expenditures on antidepressants in Canada are rapidly increasing; yet few studies have analyzed the characteristics of antidepressant users. This study investigated the prevalence and incidence of antidepressant use in British Columbia over eight years. METHODS: Antidepressant utilization and demographic data were assessed for the population of British Columbia from 1996 to 2004. Prescription claims were identified within the PharmaNet database for serotonin reuptake inhibitors (SSRI), tricyclics, monoamine oxidase inhibitors, bupropion (categorized separately for smoking cessation), and "novel" antidepressants, such as venlafaxine. Incident utilization (dispensed "first" antidepressant after two years without an antidepressant claim) and prevalent utilization were analyzed. All cohort members were required to have continuous registration with British Columbia medical services for at least two years before the first antidepressant claim. RESULTS: Prevalence of antidepressant use doubled, from 34 to 72 users per 1,000 population, between 1996 and 2004. The prevalence of particular classes of antidepressants also changed over time. Prevalence of novel antidepressants and SSRIs increased, although incidence of SSRIs decreased. Prevalent and incident use of bupropion for smoking cessation peaked in 1999 but then declined. Quarterly incident antidepressant use increased in 1998 and 1999 (6.5 and 11.3 users per 1,000) but decreased through 2004 (4.2 users per 1,000). Those aged 20 to 44 years and those aged 45 to 64 years showed the greatest peak in incident antidepressant use. A socioeconomic gradient in prescribing was observed. CONCLUSIONS: Prevalent antidepressant use has increased dramatically since 1996. By contrast, incident use increased from 1998 to 1999 but then decreased through 2004. Many complex factors likely contribute to antidepressant prescribing patterns.


Related Article:

January 2007: This Month's Highlights
Psychiatr Serv 2007 58: 7. [Full Text] [PDF]



This article has been cited by other articles:


Home page
CMAJHome page
D. Deshauer MD MSc, D. Moher PhD, D. Fergusson PhD, E. Moher BA, M. Sampson MLIS, and J. Grimshaw MD PhD
Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials
Can. Med. Assoc. J., May 6, 2008; 178(10): 1293 - 1301.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org